Applied Clinical Trials-09-01-2020

News Notes

September 17, 2020

29

9

A compilation of recent notable news developments that pertain to the clinical trials industry.

Debate Accelerates Over Who Gets COVID Vaccine First

September 17, 2020

29

9

As biopharma companies and research institutes advance the development of promising vaccines against COVID-19, policy makers and health officials have intensified deliberations on strategies for ensuring fair and equitable distribution of anticipated preventives.

FDA May Delay Approval of Drugs Where Necessary Inspection is Not Feasible

September 17, 2020

29

9

FDA to resume “prioritized domestic inspections” for certain regulated products put on hold by COVID-19.

Decentralized Trials: Opening New Opportunities in Clinical Research

September 17, 2020

29

9

Rasmus Hogreffe, former Head of Virtual Trials at LEO Innovation Lab, and current VP of Decentralized Trial Innovation at Medable, and Morten Kirkegaard, Head of Clinical Operations and Co-founder at REDO-neurosystems, discuss their experiences with decentralized trials.

The Rise of FSP Outsourcing in Drug Development

September 17, 2020

29

9

Industry experts share their thoughts on the evolution of the functional service provider model, as demand for flexible resourcing grows.

Small Biopharma and CROs: Seeking Stronger Synergies

September 17, 2020

29

9

Stakes are high for emerging biopharmaceutical companies to get their relationships with CRO partners right from the outset.

Applied Clinical Trials, September 2020 Issue (PDF)

September 17, 2020

29

9

Click the title above for a link to open the Applied Clinical Trials September 2020 issue in an interactive PDF format.

EU Makes More Vaccine Deals as Questions Mount Over Terms

September 17, 2020

29

9

The European Commission has concluded exploratory talks, with Moderna, over the purchase of a fifth potential vaccine against COVID-19.

Integration of Point-of-Care Devices in Clinical Trials

September 17, 2020

29

9

A look at the future of clinical trial laboratory testing amid the emerging use of new devices at the point of care.

EU Planning to Respond to Drug Innovation With Smarter Regulation by 2025

September 17, 2020

29

9

Europe is aiming to improve its medium-term planning for citizens' health with an agenda that aims to "enable and leverage research and innovation in regulatory science."

ACT Online

September 17, 2020

29

9

A compilation of ACT's most popular content from the previous month plus a look at upcoming webcasts.